Sunitinib Sandoz 37.5 mg hard capsules Malta - English - Malta Medicines Authority

sunitinib sandoz 37.5 mg hard capsules

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - sunitinib - hard capsule - sunitinib 37.5 mg - antineoplastic agents

Sunitinib Sandoz 50 mg hard capsules Malta - English - Malta Medicines Authority

sunitinib sandoz 50 mg hard capsules

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents

Dutasteride/Tamsulosin Sandoz 0.5mg/0.4mg Hard Capsules Malta - English - Malta Medicines Authority

dutasteride/tamsulosin sandoz 0.5mg/0.4mg hard capsules

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 mg tamsulosin hydrochloride 0.4 mg - urologicals

Rivastigmine Sandoz Transdermal Patch 13.3mg/24hours Malta - English - Malta Medicines Authority

rivastigmine sandoz transdermal patch 13.3mg/24hours

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - rivastigmine - transdermal patch - rivastigmine 13.3 mg/24 h - psychoanaleptics

Azacitidine Sandoz 25 mg/ml powder for suspension for injection Malta - English - Malta Medicines Authority

azacitidine sandoz 25 mg/ml powder for suspension for injection

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - powder for suspension for injection - azacitidine 25 mg/ml - antineoplastic agents

Enzalutamide Sandoz 40 mg film-coated tablets Malta - English - Malta Medicines Authority

enzalutamide sandoz 40 mg film-coated tablets

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - film-coated tablet - enzalutamide 40 mg - endocrine therapy

Enzalutamide Sandoz 80 mg film-coated tablets Malta - English - Malta Medicines Authority

enzalutamide sandoz 80 mg film-coated tablets

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - film-coated tablet - enzalutamide 80 mg - endocrine therapy

SANDOZ VENLAFAXINE XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz venlafaxine xr venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack

alembic pharmaceuticals australia pty ltd - venlafaxine hydrochloride, quantity: 169.8 mg (equivalent: venlafaxine, qty 150 mg) - capsule, modified release - excipient ingredients: gelatin; ethylcellulose; sunset yellow fcf; povidone; magnesium stearate; microcrystalline cellulose; brilliant blue fcf; copovidone; allura red ac; purified talc; colloidal anhydrous silica; titanium dioxide; propylene glycol; ethanol; isopropyl alcohol; shellac; tert-butyl alcohol; sodium hydroxide - sandoz venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.

SANDOZ VENLAFAXINE  XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz venlafaxine xr venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack

alembic pharmaceuticals australia pty ltd - venlafaxine hydrochloride, quantity: 84.9 mg (equivalent: venlafaxine, qty 75 mg) - capsule, modified release - excipient ingredients: iron oxide black; colloidal anhydrous silica; ethylcellulose; iron oxide red; magnesium stearate; microcrystalline cellulose; povidone; purified talc; titanium dioxide; gelatin; copovidone; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia - sandoz venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.

FINGOLIMOD SANDOZ fingolimod (as hydrochloride) 0.5 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

fingolimod sandoz fingolimod (as hydrochloride) 0.5 mg capsule blister pack

sandoz pty ltd - fingolimod hydrochloride, quantity: 0.56 mg (equivalent: fingolimod, qty 0.5 mg) - capsule, hard - excipient ingredients: mannitol; iron oxide yellow; magnesium stearate; gelatin; titanium dioxide - fingolimod sandoz is indicated for the treatment of adult and paediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.